|
1.
|
Sculier JP: Nonsmall cell lung cancer. Eur
Respir Rev. 22:33–36. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Saadeddin A: Radiotherapy for NSCLC:
review of conventional and new treatment techniques. J Infect
Public Health. 5(Suppl 1): S45–S49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Hennon MW and Yendamuri S: Advances in
lung cancer surgery. J Carcinog. 11:212012. View Article : Google Scholar
|
|
4.
|
Nadkar A, Pungaliya C, Drake K, et al:
Therapeutic resistance in lung cancer. Expert Opin Drug Metab
Toxicol. 2:753–777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ryan JL: Ionizing radiation: the good, the
bad, and the ugly. J Invest Dermatol. 132:985–993. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Verger A, Perdomo J and Crossley M:
Modification with SUMO. A role in transcriptional regulation. EMBO
Rep. 4:137–142. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Wang Y and Dasso M: SUMOylation and
deSUMOylation at a glance. J Cell Sci. 122:4249–4252. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Yeh ET: SUMOylation and De-SUMOylation:
wrestling with life’s processes. J Biol Chem. 284:8223–8227.
2009.PubMed/NCBI
|
|
9.
|
Bawa-Khalfe T and Yeh ET: SUMO losing
balance: SUMO proteases disrupt SUMO homeostasis to facilitate
cancer development and progression. Genes Cancer. 1:748–752. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Cheng J, Kang X, Zhang S and Yeh ET:
SUMO-specific protease 1 is essential for stabilization of HIF1α
during hypoxia. Cell. 131:584–595. 2007.PubMed/NCBI
|
|
11.
|
Yu L, Ji W, Zhang H, et al: SENP1-mediated
GATA1 deSUMOylation is critical for definitive erythropoiesis. J
Exp Med. 207:1183–1195. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Bawa-Khalfe T, Cheng J, Lin SH, Ittmann MM
and Yeh ET: SENP1 induces prostatic intraepithelial neoplasia
through multiple mechanisms. J Biol Chem. 285:25859–25866. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Bettermann K, Benesch M, Weis S and
Haybaeck J: SUMOylation in carcinogenesis. Cancer Lett.
316:113–125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Qiao Z, Wang W, Wang L, et al: Design,
synthesis, and biological evaluation of benzodiazepine-based
SUMO-specific protease 1 inhibitors. Bioorg Med Chem Lett.
21:6389–6392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Chen Y, Wen D, Huang Z, et al:
2-(4-Chlorophenyl)-2-oxoethyl 4-benzamidobenzoate derivatives, a
novel class of SENP1 inhibitors: Virtual screening, synthesis and
biological evaluation. Bioorg Med Chem Lett. 22:6867–6870. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hanai K, Babazono T, Nyumura I, et al:
Involvement of visceral fat in the pathogenesis of albuminuria in
patients with type 2 diabetes with early stage of nephropathy. Clin
Exp Nephrol. 14:132–136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Taneja N, Davis M, Choy JS, et al: Histone
H2AX phosphorylation as a predictor of radiosensitivity and target
for radiotherapy. J Biol Chem. 279:2273–2280. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Xu Y, Li J, Zuo Y, et al: SUMO-specific
protease 1 regulates the in vitro and in vivo growth of colon
cancer cells with the upregulated expression of CDK inhibitors.
Cancer Lett. 309:78–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Li X, Lee YK, Jeng JC, et al: Role for
KAP1 serine 824 phosphorylation and sumoylation/desumoylation
switch in regulating KAP1-mediated transcriptional repression. J
Biol Chem. 282:36177–36189. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Yang Y, Fu W, Chen J, et al: SIRT1
sumoylation regulates its deacetylase activity and cellular
response to genotoxic stress. Nat Cell Biol. 9:1253–1262. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Lindberg MJ, Popko-Scibor AE, Hansson ML
and Wallberg AE: SUMO modification regulates the transcriptional
activity of MAML1. FASEB J. 24:2396–2404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Van Nguyen T, Angkasekwinai P, Dou H, et
al: SUMO-specific protease 1 is critical for early lymphoid
development through regulation of STAT5 activation. Mol Cell.
45:210–221. 2012.PubMed/NCBI
|
